Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03956758
Other study ID # RECHMPL19_0233
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date April 1, 2019
Est. completion date April 1, 2019

Study information

Verified date November 2019
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In 2016, the number of discoveries of HIV seropositivity is estimated at about 6000 in France. Men who have sex with men (MSM) account for 44% of these infections (68% in the Occitanie region). For the past ten years, there have been new practices of sexual drug use among MSM referred to as Chemsex. These practices expose to sexual risks but also to those related to the consumption of drugs making this population more at risk to get infectious contaminations. In the "PREVAGAY study" conducted in Montpellier in 2015, about 30% of MSM included said they had consumed at least one psychoactive product before or during sex during the last 12 months. In addition, this percentage was significantly higher among HIV-positive men (51% versus 24% of HIV-negative men) and 1% (N = 9) had practiced Slam (Sexual Injection). The results of this study also showed that PreP (Prophylaxis Pre-exposure to HIV) was known by 52% of MSM included and 4% (N = 4) had already used it in the last 12 months. Several observations are needed: many ChemSex users do not use the PreP despite the fact that its effectiveness has been proven in many studies.

The social sciences have been studying the HIV epidemic since its emergence. In the era of HIV chronic disease, the sociologist Gabriel Girard wanted to question the pessimistic observation of epidemiological studies in his thesis work. Some contradictory logics explains this epidemiology of HIV which is maintained, particularly in Montpellier despite the arrival of the PreP.

The main objective of our study is to explore the reflexive logic structuring the report to HIV prevention by MSM practicing ChemSex in Montpellier, in the context of the appearance and dissemination of the PreP.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date April 1, 2019
Est. primary completion date April 1, 2019
Accepts healthy volunteers
Gender Male
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Men who have sex with men (MSM)

- living in Montpellier

- using chemsex drugs at least one during sexual intercourse

Exclusion Criteria:

- under 18 years

- seropositive HIV

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Semi-directed interview
Semi-directed interview on ChemSex practice

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Outcome

Type Measure Description Time frame Safety issue
Primary report to HIV report to HIV contamination during Chemsex 1 day